Ellen Baron is the Managing Director of Biopharmaceuticals at Outcome Capital, a position she has held since January 2017.
Based in the United States, Ellen has extensive experience in the biopharmaceutical sector.
She served on the Board of Directors for TetraGenetics Inc. from December 2018 to September 2021.
Prior to her current role, she was a Managing Director at Healthios Capital Markets, LLC from April 2012 to January 2017.
Ellen also held the position of Partner at Oxford Bioscience Partners from 2003 to 2010 and was the Chair of the Executive Board at the Institute for Pediatric Innovation from 2007 to 2009.
Earlier in her career, she worked at Schering-Plough, where she held various roles in business development from 1982 to 2001.